2025 Retina Update, Part 1: Injectables in the Medical Retina Space
Jan 23, 2025•44 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related macular degeneration (AMD) therapies, private equity acquisitions, and the new drug pipeline.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
For the best experience, listen in Metacast app for iOS or Android